Remote Monitoring for Diabetic Foot Ulcers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two methods for monitoring diabetic foot ulcers: using a smartphone app at home and visiting a clinic in person. Researchers aim to determine if remote monitoring can match the effectiveness of traditional methods. Participants will either use the app to send wound pictures to doctors or attend regular clinic check-ups. This trial suits individuals with a diabetic foot ulcer who are comfortable using a smartphone for wound care. As an unphased trial, it offers a unique opportunity for patients to contribute to innovative research that could improve future diabetic foot ulcer care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that remote wound monitoring technology is safe for diabetic foot ulcers?
Research has shown that patients generally receive remote technology for monitoring diabetic foot ulcers well. Studies have found that using a smartphone app to track and manage these wounds is practical and safe. This approach does not appear to cause more side effects than traditional in-person check-ups. However, one study found that while ulcer healing was similar between remote and standard care, the telehealth group had a higher death rate. This suggests that remote monitoring is generally safe, but patients should maintain close contact with their healthcare providers.12345
Why are researchers excited about this trial?
Researchers are excited about remote wound monitoring technology for diabetic foot ulcers because it introduces a new way to track and manage wounds using a smartphone app. Unlike traditional care that requires frequent in-clinic visits, this technology allows patients to self-assess their wounds at home during regular dressing changes and send updates to doctors remotely. This could lead to more timely interventions, potentially improving healing rates and convenience for patients who might struggle with frequent clinic visits.
What evidence suggests that remote wound monitoring technology is effective for diabetic foot ulcers?
Research has shown that using a smartphone app to monitor wounds remotely can effectively manage diabetic foot ulcers. In this trial, some participants will use remote wound monitoring technology, which previous findings have identified as a cost-effective way to track wound healing. The app employs artificial intelligence (AI) to analyze the wound's condition. Early results suggest that patients can independently check their wounds and send crucial information to doctors without in-person visits. This method aims to simplify monitoring, potentially leading to better care and faster healing for individuals with diabetic foot ulcers.12678
Who Is on the Research Team?
Caitlin Hicks, MD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 with diabetic foot ulcers who are receiving treatment, can use a smartphone, and speak English. It's not suitable for those without help to scan wounds in hard-to-reach areas, have infrequent dressing changes, or have wounds too large for a single app scan.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either remote wound monitoring using a smartphone app or standard in-person monitoring for diabetic foot ulcers
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remote wound monitoring technology
Remote wound monitoring technology is already approved in United States for the following indications:
- Diabetic foot ulcers
- Chronic wound management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator